Agenus | AGEN - Passivo Circulante





Passivo Circulante Alterar Data
AbbVie USD 42.1B 1.19B 2026-03
Agenus USD 249.24M 74.25M 2026-03
Amgen USD 24.96B 534M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Celldex Therapeutics USD 51.47M 481K 2026-03
CSL USD 4.61B 207M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Glaxosmithkline GBP 22.43B 6.39B 2026-03
Incyte USD 1.49B 25.52M 2026-03
Intrexon USD 23.02M 38K 2024-06
J&J USD 54.9B 2.82B 2026-06
Jiangsu Hengrui CNY 5.64B 732.51M 2026-03
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
MacroGenics USD 95.94M 52.82M 2026-03
Merck EUR 9.35B 307M 2026-03
Merck USD 26.94B 1.38B 2026-03
Northwest Biotherapeutics USD 87.9M 3.98M 2025-09
Novartis USD 31.37B 4.1B 2026-03
Novavax USD 342.46M 117.49M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Veracyte USD 56.11M 3.82M 2026-03